Procter & Gamble (NYSE:PG) PT Raised to $160.00

Procter & Gamble (NYSE:PG) had its price target increased by research analysts at DA Davidson from $159.00 to $160.00 in a research note issued to investors on Monday, Benzinga reports. The firm presently has a “neutral” rating on the stock. DA Davidson’s target price would suggest a potential downside of 5.73% from the stock’s previous close. DA Davidson also issued estimates for Procter & Gamble’s Q2 2025 earnings at $1.93 EPS.

PG has been the topic of a number of other research reports. Deutsche Bank Aktiengesellschaft boosted their price objective on Procter & Gamble from $171.00 to $176.00 and gave the stock a “buy” rating in a research report on Wednesday, July 17th. JPMorgan Chase & Co. boosted their price target on Procter & Gamble from $179.00 to $186.00 and gave the stock an “overweight” rating in a report on Thursday, September 19th. Dbs Bank lowered shares of Procter & Gamble from a “strong-buy” rating to a “hold” rating in a report on Thursday, August 1st. DZ Bank raised shares of Procter & Gamble from a “hold” rating to a “buy” rating and set a $190.00 target price on the stock in a report on Thursday, August 29th. Finally, Stifel Nicolaus raised their price target on shares of Procter & Gamble from $157.00 to $161.00 and gave the company a “hold” rating in a research note on Monday, July 22nd. Nine equities research analysts have rated the stock with a hold rating, thirteen have issued a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $177.00.

Procter & Gamble Trading Up 0.1 %

Shares of PG stock opened at $169.73 on Monday. Procter & Gamble has a fifty-two week low of $142.50 and a fifty-two week high of $177.94. The stock’s fifty day moving average price is $171.87 and its two-hundred day moving average price is $167.43. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.53 and a current ratio of 0.73. The company has a market cap of $400.59 billion, a PE ratio of 29.26, a P/E/G ratio of 3.72 and a beta of 0.41.

Procter & Gamble (NYSE:PG) last released its quarterly earnings data on Friday, October 18th. The company reported $1.93 earnings per share for the quarter, beating the consensus estimate of $1.90 by $0.03. The business had revenue of $21.74 billion for the quarter, compared to analyst estimates of $21.99 billion. Procter & Gamble had a return on equity of 33.46% and a net margin of 17.71%. Procter & Gamble’s revenue was down .6% compared to the same quarter last year. During the same period last year, the firm posted $1.83 earnings per share. Equities analysts predict that Procter & Gamble will post 6.98 EPS for the current fiscal year.

Insider Buying and Selling

In related news, insider Susan Street Whaley sold 634 shares of the stock in a transaction on Wednesday, October 2nd. The stock was sold at an average price of $171.65, for a total value of $108,826.10. Following the transaction, the insider now directly owns 19,341 shares in the company, valued at $3,319,882.65. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In related news, insider Balaji Purushothaman sold 8,842 shares of the company’s stock in a transaction on Thursday, August 1st. The stock was sold at an average price of $164.90, for a total transaction of $1,458,045.80. Following the completion of the sale, the insider now owns 11,537 shares in the company, valued at approximately $1,902,451.30. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, insider Susan Street Whaley sold 634 shares of the stock in a transaction on Wednesday, October 2nd. The shares were sold at an average price of $171.65, for a total value of $108,826.10. Following the completion of the sale, the insider now directly owns 19,341 shares of the company’s stock, valued at $3,319,882.65. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 383,194 shares of company stock valued at $65,140,718. 0.18% of the stock is owned by company insiders.

Institutional Trading of Procter & Gamble

Several institutional investors have recently made changes to their positions in the company. Itau Unibanco Holding S.A. purchased a new position in Procter & Gamble during the second quarter worth about $28,000. Fairway Wealth LLC bought a new position in shares of Procter & Gamble in the second quarter valued at approximately $29,000. Ruedi Wealth Management Inc. increased its position in shares of Procter & Gamble by 64.7% during the first quarter. Ruedi Wealth Management Inc. now owns 196 shares of the company’s stock valued at $32,000 after acquiring an additional 77 shares during the last quarter. POM Investment Strategies LLC bought a new stake in Procter & Gamble during the second quarter worth $34,000. Finally, Quest Partners LLC bought a new stake in Procter & Gamble during the second quarter worth $36,000. Institutional investors own 65.77% of the company’s stock.

About Procter & Gamble

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.